Prevalence and Clinical Implications of Epstein–Barr Virus Infection in <i>De Novo</i> Diffuse Large B-Cell Lymphoma in Western CountriesChi Young Ok, Ken H. Young, J. Han van Krieken et al.|Clinical Cancer Research|2014Cited by 143
Prevalence and Clinical Implications of Epstein-Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western CountriesWeiyun Z. Ai, John P. Farnen, Eric D. Hsi et al.|VBN Forskningsportal (Aalborg Universitet)|2020Cited by 19
Supplementary Figure 1 from Prevalence and Clinical Implications of Epstein–Barr Virus Infection in <i>De Novo</i> Diffuse Large B-Cell Lymphoma in Western CountriesChi Young Ok, Ken H. Young, Ling Li et al.|Unknown|2023Cited by 0
Supplementary Table 1 from Prevalence and Clinical Implications of Epstein–Barr Virus Infection in <i>De Novo</i> Diffuse Large B-Cell Lymphoma in Western CountriesChi Young Ok, Ken H. Young, Ling Li et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from Prevalence and Clinical Implications of Epstein–Barr Virus Infection in <i>De Novo</i> Diffuse Large B-Cell Lymphoma in Western CountriesChi Young Ok, Ken H. Young, Michael Møller et al.|Unknown|2023Cited by 0